New study uses MRI to track fatty liver in diabetic patients

NCT ID NCT03864510

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how common and severe fatty liver disease is in people with type 2 diabetes. Researchers used advanced MRI scans to measure liver fat, inflammation, and scarring. 317 patients were checked twice, three years apart, to see how the disease changes over time. The goal was to better understand who gets worse and why.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NAFLD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ekholmen primary health care centre

    Linköping, Swedish, 58185, Sweden

  • Åby primary health care centre

    Norrköping, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.